Once a high-risk individual is diagnosed with COVID-19, early treatment with antivirals is the best existing strategy to decrease the risk of serious illness and prevent hospitalization. All available COVID-19 oral antivirals have now transitioned to the commercial market after almost two years of being available free of charge through the US government, representing a significant change for patients and providers alike. This health alert will outline the broad changes in the transition, give several resources for more information, as well as how to obtain free or lower-cost medication for patients who qualify, and highlights the importance of continuing to offer and prescribe therapeutic agents for COVID-19 when appropriate.
Please see the full CDPH Health Advisory here: https://www.cdph.ca.gov/Programs/OPA/Pages/CAHAN/Update-on-COVID-19-Medications-and-Transition-to-Commercial-Marketplace.aspx
